Literature DB >> 81681

Platelet and plasma beta thromboglobulin in myeloproliferative syndromes and secondary thrombocytosis.

B J Boughton, M J Allington, A King.   

Abstract

Elevated plasma beta thromboglobulin (betatg) and decreased intracellular platelet betatg were found in patients with various myeloproliferative disorders. In secondary thrombocytosis, similar, but less marked changes were found. The abnormalities were increased during episodes of clinical thrombosis and could be suppressed in two-thirds of cases by aspirin therapy.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 81681     DOI： 10.1111/j.1365-2141.1978.tb03646.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  6 in total

1.  Hepatic and portal vein-thrombosis.

Authors:  B J Boughton
Journal:  BMJ       Date:  1991-01-26

Review 2.  Platelet markers of thromboembolic disease.

Authors:  H Wohl
Journal:  West J Med       Date:  1981-07

3.  Release of beta-thromboglobulin during the preparation, in vitro storage and cryopreservation of platelet concentrates.

Authors:  M A Taylor
Journal:  J Clin Pathol       Date:  1983-07       Impact factor: 3.411

4.  Gray platelet syndrome: selective alpha-granule deficiency and thrombocytopenia due to increased platelet turnover.

Authors:  M Köhler; P Hellstern; E Morgenstern; C Mueller-Eckhardt; R Berberich; R J Meiser; P Scheffler; E Wenzel
Journal:  Blut       Date:  1985-06

5.  The significance of the aminoterminal propeptide of type III procollagen in paroxysmal nocturnal haemoglobinuria and myelofibrosis.

Authors:  E Vellenga; N H Mulder; A K van Zanten; H O Nieweg; M G Woldring
Journal:  Eur J Nucl Med       Date:  1983

6.  Markers of endothelial and in vivo platelet activation in patients with essential thrombocythemia and polycythemia vera.

Authors:  Marina Karakantza; Nikolaos C Giannakoulas; Panagiotis Zikos; George Sakellaropoulos; Alexandra Kouraklis; Anthi Aktypi; Ioannis C Metallinos; Eleni Theodori; Nicholas C Zoumbos; Alice Maniatis
Journal:  Int J Hematol       Date:  2004-04       Impact factor: 2.490
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.